Washington HB 2325: Concerning the prescription drug monitoring program.

Status: First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (as of 2018-01-08)

State: Washington · Session: 2017-2018 · Bill: HB 2325

Subjects: HEALTH CARE PROFESSIONS AND PROVIDERS, DRUGS

Sponsors: Riccelli, Appleton, Doglio, Frame, Gregerson, Haler, Harris, Jinkins, Macri, Pellicciotti, Pollet, Ryu, Stonier, Tharinger, Valdez

View Washington HB 2325 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.